FANCL Antikörper
-
- Target Alle FANCL Antikörper anzeigen
- FANCL (Fanconi Anemia, Complementation Group L (FANCL))
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser FANCL Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant fusion protein of human FANCL (NP_060532.2).
- Isotyp
- IgG
- Top Product
- Discover our top product FANCL Primärantikörper
-
anti-Fanconi Anemia, Complementation Group L (FANCL) (AA 1-375) antibody
FANCL Reaktivität: Human WB, IF, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Fanconi Anemia, Complementation Group L (FANCL) (AA 138-248) antibodyFANCL Reaktivität: Human ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Fanconi Anemia, Complementation Group L (FANCL) (AA 274-302), (C-Term) antibodyFANCL Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB23901 unconjugated
anti-Fanconi Anemia, Complementation Group L (FANCL) (AA 1-375) antibodyFANCL Reaktivität: Human WB, IF Wirt: Maus Polyclonal unconjugated
anti-Fanconi Anemia, Complementation Group L (FANCL) (AA 1-375) antibodyFANCL Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-Fanconi Anemia, Complementation Group L (FANCL) (AA 1-255) antibodyFANCL Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Fanconi Anemia, Complementation Group L (FANCL) (Internal Region) antibodyVerified FANCL Reaktivität: Human WB, ELISA Wirt: Ziege Polyclonal unconjugated
anti-Fanconi Anemia, Complementation Group L (FANCL) (AA 143-192) antibodyFANCL Reaktivität: Human, Affe WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- WB 1:200-1:2000 IHC 1:20-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- FANCL (Fanconi Anemia, Complementation Group L (FANCL))
- Andere Bezeichnung
- FANCL (FANCL Produkte)
- Hintergrund
- The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity, they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group L. Alternative splicing results in two transcript variants encoding different isoforms.
- Molekulargewicht
-
Observed_MW: 38 kDa
Calculated_MW: 42 kDa/43 kDa
- Gen-ID
- 55120
- UniProt
- Q9NW38
- Pathways
- DNA Reparatur
-
